M&A Deal Summary |
|
---|---|
Date | 2014-10-01 |
Target | Omega Laboratories |
Sector | Life Science |
Buyer(s) | Sagent Pharmaceuticals |
Deal Type | Add-on Acquisition |
Deal Value | 95M CAD |
Advisor(s) | PwC Corporate Finance (Financial) Fasken Martineau DuMoulin (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2006 |
Sector | Life Science |
Employees | 440 |
Revenue | 318M USD (2015) |
Sagent Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products with a specific emphasis on injectables.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 1 |
State (Ohio) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2014) | 1 of 1 |
Size (of disclosed) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2023-05-15 |
Omega Laboratories
Mogadore, Ohio, United States Omega Laboratories is a pharmaceutical and specialty healthcare products company focused on manufacturing, innovation, quality, and rapid R&D development for the Canadian and global markets. The Hospital Division manufactures sterile vial format injectables, antiseptics, oncology injectables, and non-injectable pharmaceuticals for the Canadian and export markets and the Allergy and Phlebology Divisions provide specialized products and services for Canadian customers. Omega Laboratories was founded in 1958 and is based in Mogadore, Ohio. |
Sell | - |